Products | March 16, 2010

flurpiridaz F 18 PET MPI

flurpiridaz F 18 PET MPI

Related Content

Sirona Advanced Imaging Suite Gets FDA 510(k) Clearance
News | FDA
Sirona Advanced Imaging Suite Gets FDA 510(k) Clearance

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
News | Prostate Cancer
High-Speed Whole-Body SPECT Tracks Tumor Evolution, Helps Optimize Prostate Cancer Treatment Options

Sept. 26, 2025 — A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently ...

Time October 03, 2025
arrow
New PET Tracer Enables Same-Day Imaging of Triple-Negative Breast, Urothelial Cancers
News | Radiopharmaceuticals and Tracers
New PET Tracer Enables Same-Day Imaging of Triple-Negative Breast, Urothelial Cancers

Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative ...

Time September 18, 2025
arrow
News | Prostate Cancer
Study: PSMA PET/CT Prior to Salvage Radiotherapy Improves Overall Survival for Prostate Cancer Patients

Aug. 13, 2025 — A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer ...

Time August 15, 2025
arrow
Mammography and PET/CT Viewers Added to New Lantern's AI Radiology Platform
News | Mammography
Mammography and PET/CT Viewers Added to New Lantern's AI Radiology Platform

Aug. 5, 2025 — New Lantern has announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET ...

Time August 05, 2025
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Prostate Cancer
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
The deployment of DL segmentation methods in 18F-fluciclovine PET/CT imaging represents an intriguing research direction for precision medicine in salvage prostate cancer care
News | Prostate Cancer
Deep Learning-assisted Lesion Segmentation in PET/CT Imaging: A Feasibility Study for Salvage Radiation Therapy in Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Positron will install the Attrius in Q4 2024 in accordance with the facility’s timeline.
News | PET Imaging
Positron Corporation Announces Attrius PET System Sale

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
The CPIC will be a leading advocate for fair and transparent coverage and reimbursement policies that facilitate access to cardiac PET
News | PET Imaging
Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis
News | SPECT-CT
Novel Radiotracer Produces High Quality Images of “Alzheimer’s Disease of the Heart”

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now